Clinical Trials List
2018-06-26 - 2030-12-31
Phase II
Recruiting7
ICD-10C91.10
Chronic lymphocytic leukemia of B-cell type not having achieved remission
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 唐世豪 Division of Hematology & Oncology
- Shih-Feng Cho Division of Hematology & Oncology
- Hui-Ching Wang Division of Hematology & Oncology
- Hui-Hua Hsiao Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ching Yun Hsieh Division of Hematology & Oncology
- Ming-Hung Tsai Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
- Tzu-Ting Chen Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chieh-Lung Cheng Division of Hematology & Oncology
- 劉高郎 Division of Hematology & Oncology
- 林明恩 Division of Hematology & Oncology
- Jih-Luh Tang Division of Hematology & Oncology
- CHENG-HONG TSAI Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- 林建廷 Division of Hematology & Oncology
- 田豐銘 Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
- Chien-Chin Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
Co-Principal Investigator
Audit
None
Co-Principal Investigator
- 洪玉馨 Division of Hematology & Oncology
- Tung-Liang Lin Division of Hematology & Oncology
- 張 鴻 Division of Hematology & Oncology
- 高小雯 Division of Hematology & Oncology
- Po-Nan Wang Division of Hematology & Oncology
- Hung Chang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
Co-Principal Investigator
- - - Division of Hematology & Oncology
- CHENG-HONG TSAI Division of Hematology & Oncology
- 田豐銘 Division of Hematology & Oncology
- Chieh-Lung Cheng Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jeng-Shiun Du Division of Hematology & Oncology
- Shih-Feng Cho Division of Hematology & Oncology
- Hui-Ching Wang Division of Hematology & Oncology
- Hui-Hua Hsiao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
110 participants
